This Diabetes-in-Control news piece begins,
“Diabetes rates among adults in the United States are finally leveling off, new
data from the Centers for Disease Control and Prevention suggest.” The headline
of the piece is less speculative. It simply declares,
“Diabetes Rates in the US Have Finally Plateaued.” Headlines often do that.
They try to grab your attention. In this case, with the primary audience being
clinicians and other health care providers, it also has a self-congratulatory
tone that is entirely unwarranted, as the “fine print” of the article makes
clear.
The Diabetes-in-Control piece is based on “findings from a
National Health Interview Survey (NHIS) on both prevalence and incidence of
diabetes from 1980 to 2012” published online in the Journal of the American Medical Association (JAMA). Prevalence refers to its
widespread, existential presence
while incidence, in the
epidemiological sense, relates to the initial
appearance of a new condition (diabetes)
in the population. Both, in the NHIS survey, were self-reported by the patient.
The findings which led to the headline are a reduction of the incidence of type 2 diabetes in
the general population.
Among the
664,969 adults aged 20 to 79 who responded to the NHIS survey, the prevalence of diabetes was 3.5% in 1990,
7.9% in 2008, and 8.3% in 2012. The incidence
per 1000 people was 3.2 in 1990, 8.8 in 2008 and 7.1 in 2012. The annual
percentage change in both prevalence and incidence was not significant in the
1980s; however, both jumped significantly from 1990 to 2008. Then, from 2008 to
2012, prevalence plateaued and incidence diminished significantly.
“However,” Diabetes-in-Control highlighted, “both
diabetes incidence and prevalence continued to increase at a significantly
greater rate for young adults aged 20 to 44 years compared with older adults
and for black and Hispanic adults compared with white adults.” In addition,
“The rate of increase in prevalence was higher for those with a high school education
or less compared with those with more than a high school education.” Hmmm.
Another sociodemographic disparity. I wonder if dietary choices had anything to
do with that. (Catch the sarcasm, pullese.)
The
sub-head in the article asks, “Is It All About Obesity?” Phrasing it as a
question, of course, begs the answer. The author notes that a little
mumbo-jumbo (a statistical adjustment) “reduced the annual percent change in
incidence by about a third…” with the study author telling Diabetes-in-Control, “This suggests that the leveling off of
obesity that occurred over the same period explains a large part of the
diabetes plateau, but not all of it.” The knock-out punch was, “The BMIs in the
NHIS study were self-reported and therefore most likely underestimated.” Do ya
think? Do you even know your own BMI?
Searching
for another explanation for “the diabetes plateau” the Diabetes-in-Control author speculates, “Beyond obesity, other
possible influences on the reduction in diabetes rates include improvements in
diet and activity levels and changes in diagnostic criteria.” Wow! If I read
this correctly, the author implies that we are getting obese at a lower rate than before; that she adduces this from the
finding of this epidemiological study that since the incidence of diabetes
diminished significantly from 2008 to 2012, that obesity associated with the
incidence and prevalence of type 2 diabetes did as well.
The only
evidence she offers for this association – the decline in incidence of type 2
diabetes with an assumed decline in
obesity, contrary to all other studies of the population known to me – is
“improvements in diet and activity levels.” Oh, how I wish that it were so.
That we could realize an actual result by just saying it over and over: Improve
your diet and activity levels (eat a balanced, USDA recommended
one-size-fits-all diet and exercise more), and abracadabra you will become
thin.
Maybe the
explanation for “the diabetes plateau” lies instead in the “changes in the
diagnostic criteria.” Do you think this could affect the way that 664,969
people self-reported on their condition? Could that alone have “confounded” the
study results to the point that all the other “statistical adjustments” were
totally insignificant by comparison? Do ya think?
“The 1997 lowering of
the fasting plasma glucose cutoff from 140 mg/dL to 126 mg/dL may have
increased the diabetes incidence…,” the CDC study author noted. I love it! “May
have,” she says. Whereas, “… the more recent [2010] shift to use HbA1c for
diagnosis may have reduced it, since HbA1c detects fewer cases of
hyperglycemia,” she said. Interesting indeed, and contrary to my own
understanding. The reason the medical establishment has shifted from “fasting”
to A1c is for the express purpose of
capturing blood glucose postprandial “excursions,” i.e. hyperglycemic spikes
due to impaired glucose tolerance (IGT) over a 3-month period. Fasting glucose
testing does not do that. It just captures impaired fasting glucose.
This comment has been removed by a blog administrator.
ReplyDeletePioglit MF Forte Tablet isn't suggested for use in breastfeeding ladies except if completely important. All the dangers and advantages ought to be examined with the specialist before taking this medication. Your primary care physician may encourage you to end breastfeeding or to end the medicine depends on your clinical condition.
ReplyDelete